相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PK/PD integration and pharmacodynamic cutoff of cefquinome against cow mastitis due to Escherichia coli
Xia Xiao et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2022)
PK/PD Modeling to Assess Rifaximin Clinical Dosage in a Mouse Model of Staphylococcus aureus-Induced Mastitis
Honglei Wang et al.
FRONTIERS IN VETERINARY SCIENCE (2021)
Evaluation of phage therapy in the treatment of Staphylococcus aureus-induced mastitis in mice
Huijun Geng et al.
FOLIA MICROBIOLOGICA (2020)
Characterization of an Enterococcus faecium strain in a murine mastitis model
I. D. Montironi et al.
JOURNAL OF APPLIED MICROBIOLOGY (2020)
Melaleuca armillarisEssential Oil in Combination With Rifaximin AgainstStaphylococcus aureusIsolated of Dairy Cows
Daniel Buldain et al.
FRONTIERS IN VETERINARY SCIENCE (2020)
Impact of direct application of biogas slurry and residue in fields: In situ analysis of antibiotic resistance genes from pig manure to fields
Chengjun Pu et al.
JOURNAL OF HAZARDOUS MATERIALS (2018)
Cloning, Expression, and Immunogenicity of Fimbrial-F17A Subunit Vaccine against Escherichia coli Isolated from Bovine Mastitis
Wei Chen et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Efficacy of Cefquinome against Escherichia coli Environmental Mastitis Assessed by Pharmacokinetic and Pharmacodynamic Integration in Lactating Mouse Model
Yang Yu et al.
FRONTIERS IN MICROBIOLOGY (2017)
Applications of the pharmacokinetic/pharmacodynamic (PK/PD) analysis of antimicrobial agents
Eduardo Asin-Prieto et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2015)
In vitro activity of rifaximin against isolates from patients with small intestinal bacterial overgrowth
Aikaterini Pistiki et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Short communication: Antimicrobial efficacy of intramammary treatment with a novel biphenomycin compound against Staphylococcus aureus, Streptococcus uberis, and Escherichia coli-induced mouse mastitis
Dieter Demon et al.
JOURNAL OF DAIRY SCIENCE (2013)
Rate of transmission: A major determinant of the cost of clinical mastitis
P. M. Down et al.
JOURNAL OF DAIRY SCIENCE (2013)
Histone H3K14 and H4K8 hyperacetylation is associated with Escherichia coli induced mastitis in mice
Rahul Modak et al.
EPIGENETICS (2012)
The crisis of no new antibiotics-what is the way forward?
Laura J. V. Piddock
LANCET INFECTIOUS DISEASES (2012)
Rifaximin: New Therapeutic Indication and Future Directions
Anastasia Rivkin et al.
CLINICAL THERAPEUTICS (2011)
Economic aspects of mastitis: New developments
H. Hogeveen et al.
NEW ZEALAND VETERINARY JOURNAL (2011)
Inflammatory mediators in Escherichia coli-induced mastitis in mice
Sofie Notebaert et al.
COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES (2008)
Effects of rifaximin on bacterial virulence mechanisms at supra- and sub-inhibitory concentrations
E. A. Debbia et al.
JOURNAL OF CHEMOTHERAPY (2008)
In vitro antimicrobial activity of rifaximin against enteropathogens causing traveler's diarrhea
Joaquim Ruiz et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2007)
Toll-like receptor 4 is needed to restrict the invasion of Escherichia coli P4 into mammary gland epithelial cells in a murine model of acute mastitis
Erez Gonen et al.
CELLULAR MICROBIOLOGY (2007)
Rifaximin: A novel nonabsorbed rifamycin for gastrointestinal disorders
JA Adachi et al.
CLINICAL INFECTIOUS DISEASES (2006)
The pathogenesis and control of Staphylococcus aureus-induced mastitis:: study models in the mouse
E Brouillette et al.
MICROBES AND INFECTION (2005)
Antibacterial resistance worldwide: causes, challenges and responses
SB Levy et al.
NATURE MEDICINE (2004)
Bovine mastitis and intramammary drug delivery: review and perspectives
P Gruet et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
分享论文
